approved EB-1A
Assistant Research Professor
Electrical And Computer Engineering · Nepal · 2025-04-15
This case is from a publicly available case study. Case studies tend to feature successful outcomes and may not reflect the full range of petition results.
Framework Evaluation
3 of 3 criteria metScholarly Articles (Met)
The petitioner authored 12 journal articles and 8 conference papers in high-impact biomedical and engineering journals.
Judging (Met)
The petitioner served as a peer reviewer for at least 70 manuscripts, demonstrating his authority in the field.
Original Contributions (Met)
The petitioner's 5 granted patents and 492 citations evidence the original and significant impact of his AI-based healthcare research.
Why This Petition Was Approved
The petition was approved based on the petitioner's record of 12 peer-reviewed journal articles, 8 conference papers, and 5 granted patents. His research accumulated 492 citations, demonstrating significant influence in biomedical science and materials engineering. Additionally, his service as a reviewer for at least 70 manuscripts satisfied the judging criterion for EB-1A.
Evidence
Evidence Types
Peer Reviewed Publications
Citations
Patents
Reference Letters Independent
Reference Letters Dependent
Judging Experience
Original Contributions
Government Alignment
Evidence Submitted
- 12 peer-reviewed journal articles
- 8 peer-reviewed conference papers
- 1 first-authored abstract
- 3 preprints
- 5 granted patents
- 492 citations
- Reviewer for at least 70 manuscripts
Similar Cases
Others
Artificial Intelligence · China
WeGreened EB-1A approved
22 days 2026-01-09
The petition was approved based on a strong publication record of 18 peer-reviewed papers and over 800 citations spanning 21 countries. The petitioner also demonstrated significant professional standing through 50 completed peer reviews for selective journals and conferences. These metrics satisfied the EB-1A criteria for scholarly articles, original contributions, and judging roles.
Assistant Professor
Biotechnology · China
WeGreened EB-1A approved
40 days 2023-08-05
The petition was approved based on the petitioner's 13 peer-reviewed scientific articles and 208 citations from researchers in 28 countries. Additionally, she demonstrated her elevated position in the field by completing 23 peer reviews for various publications. These metrics satisfied the EB-1A criteria for scholarly articles, original contributions, and judging the work of others.
Professor
Research and Development · China
WeGreened EB-1A approved
6 days 2023-09-20
The petition was approved based on meeting three EB-1A criteria: scholarly articles, judging the work of others, and original contributions of major significance. Specific metrics included 38 peer-reviewed publications, 304 citations demonstrating field-wide influence, and 91 completed peer reviews for scientific venues.
Others
Engineering · China
WeGreened EB-1A approved
California 324 days 2025-02-22
The petition was approved based on a strong record of 14 total publications and 228 citations, demonstrating significant influence in communication engineering. The petitioner also provided evidence of 34 peer reviews for prominent journals and conferences. Additionally, the work was supported by prestigious international funding bodies including the NSFC, NRF Singapore, and the Australian Research Council.
Frequently Asked Questions
A approved EB-1A (I-140) petition means USCIS determined the petitioner met the eligibility requirements. For appealed cases, "sustained" means the appeal reversed a prior denial. The petitioner can proceed to the next step in the immigration process.
Browse More Cases
Case data sourced from publicly available petition decisions and case studies. Decision date: 2025-04-15.
Browse all casesAt a Glance
Outcome approved
Processing 8 days
Criteria Met 3 / 3
Evidence Types 8
EB-1A Case Data
Scraped Case Data
Total Cases 919
Success Rate 53.0%
Sustained 487
Dismissed 315
Related Pages
Get Case Insights
Compare your profile against thousands of real petition outcomes. Join the waitlist for personalized analysis.
Join Waitlist